Is sharing the CEO load better than going solo? A study by AAPL of 87 co-CEO companies between 1996 and 2020 found these businesses generated average returns of 9.5 percent, with nearly 60 percent ...
NEW DELHI: Amid volatile geopolitics and rapid shifts in markets and technology, certain companies are evaluating the idea of two leaders sharing the corner office. Over the past few weeks, global ...
American Tower (AMT) shares have seen some movement recently, catching the attention of investors interested in real estate and infrastructure stocks. With recent performance trends, many are ...
LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
Understanding the differences between AMT, CVT and DCT can help you choose the appropriate transmission for your needs. Choosing the right car transmission can be confusing. With so many options ...
American Tower beat Wall Street's sales and adjusted funds from operations (AFFO) targets in Q3. The company also raised its full-year performance targets. Some investors were looking for an even ...
The manual gearbox is dying, but in certain regions, it has a new lease of life as it is being replaced by the AMT — Automated Manual Transmission. While AMTs may not be common in the United States, ...
On Tuesday, the IRS released Notice 2025-49, which provides interim guidance regarding the application of the CAMT. The proposed regulations address the application of the CAMT and technical ...
American Tower’s (NYSE:AMT) growth outlook remains tied to muted carrier activity, with T-Mobile US (NASDAQ:TMUS) driving colocations to meet Federal Communications Commission (FCC) buildout rules ...
On Tuesday, Spotify founder and CEO Daniel Ek announced he will step down from his leadership role after nearly two decades. Ek will serve as the company’s executive chairman, and two former ...
UniQure Gene Therapy’s Clinical Trial Results Keep It on Path to Become First Huntington’s Treatment
A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...
Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback